Millennial Expands Lithium Brine Horizon at Pastos Grandes

V.ML, Millenial Lithium, lithium, Argentina
info

Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQX: MLNLF) (“Millennial” or the “Company”) is pleased to report positive drilling and analytical results from the latest exploration wells at its Pastos Grandes Project in Salta, Argentina. Two new exploration holes (PGMW18-16 and 17) have intersected, and bottomed in, lithium-bearing brine zones, with PGMW18-17 intersecting positive lithium grades in a 545 meter thick lithium-bearing horizon, including a high grade of 701 mg/L Li. A 40 person camp is being installed at the site, including a state of the art solar-hybrid power system as work advances at the site on a pilot plant to produce battery grade lithium carbonate. read more

FSD Pharma and SciCann Therapeutics to Attend the CannX International Medical Cannabis Convention in Tel Aviv Israel

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce that its Head of Scientific Advisory Board, Dr. Zohar Koren, will attend the 3rd International Medical Cannabis Conference, (“CannX”) in Tel Aviv, Israel from October 14 to 16, 2018. read more

MGX Minerals Reports Gibraltar Silicon Project Metallurgy; Suitability for Metallurgical Grade Silicon Confirmed

CSE:XMG, MGX Minerals, lithium,

MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: 1MG / OTCQB: MGXMF) announces it has received an independent evaluation and report regarding potential applications of quartzite material originating from its Gibraltar Silica Property (“Gibraltar” or the “Property”). read more

FSD Pharma Congratulates High Tide Inc. for Closing Oversubscribed Private Placement and Announces $2 Million Lead Order

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: OK9) (“FSD Pharma” or the “Company“) would like to congratulate High Tide Inc. (“High Tide“) on closing the second tranche of its brokered private placement (the “Offering“), for gross proceeds of approximately $18.3 million. The Offering, which was initially a $10 million financing, was upsized by over 83% due to strong demand from over 135 participating investors. read more

Goldplay Announces Positive Results from Sampling of Historical Core at San Marcial – Attractive Silver-Lead-Zinc Mineralization Supports Open Pit Potential

V.GPLY, Goldplay Exploration, gold

Goldplay Exploration Ltd. (TSXV: GPLY, OTCQB: GLYXF – the “Company” or “Goldplay”) is pleased to announce additional positive results from sampling of the historical core drill holes, completed in 2010 (“historical core”), from the Company’s San Marcial Project in Mexico. The high-grade results support open pit potential of the initial 500 meter long deposit. read more

FSD Pharma Begins Construction of Heritage Museum and Flagship Dispensary in Ontario

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce that construction has commenced of its heritage museum and flagship dispensary at the former Kraft plant in Cobourg, Ontario, headquarters of its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”). Local politicians and media will be in attendance at the ribbon-cutting ceremony on October 9, 2018 at 11:30 EST in Cobourg at the Head office located at 520 William Street. Honoured invited guests include Cobourg Mayor Gil Brocanier who will be in attendance and the Hon. Kim Rudd, MP for Northumberland and Peterborough South who is expected to attend. All national media are welcome with media credentials. read more

MGX Signs Definitive Agreement to Acquire Lithium Brine Projects in Chile – Permitting in Place to Commence Drill Program

CSE:XMG, MGX Minerals, lithium,

MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / OTCQB: MGXMF / FSE: 1MG) is pleased to announce it has signed the Definitive Option Agreement, after completing the due diligence in relation to the Memorandum of Understanding dated August 8th 2018, to acquire 50% of the issued shares of Chilean Lithium Salars SpA (“CLS”). CLS is a wholly owned subsidiary of Chilean Lithium Salars Pty Ltd. (“CLSH”) and holds a 100% interest in three prospective lithium exploration Projects (the “Projects”) located in Chile, including Francisco Basin, Laguna Brava and Laguna Escondida Lithium Projects. read more

Canntab Therapeutics: Cannabis in a Hard Pill

C.PILL, Canntab Therapeutics, , cannabis

Jeff Renwick and Richard Goldstein (l&r above) have been working together on the generic side of the pharmaceutical business for a decade. Developing drugs and drug delivery systems. Renwick has a total of 25 years in pharma and Goldstein was an investment banker. Their private company had two generic drugs in the pipeline and a good deal of work on extended release formulations. read more